List of insiders holdings for SELLAS Life Sciences Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Hudson Bay Capital Management LP Gerber Sander 10% Owner |
2017-02-10 18:16:17 | 0 2,037,659 |
2,037,659 | Form 4 |
| 2 | Stergiou Angelos M. President and CEO |
2025-01-14 17:34:30 | 1,244,782 0 |
1,244,782 | Form 4 |
| 3 | Kennedy Robert Eugene Vice President and CFO |
2011-04-22 11:56:37 | 404,288 379,294 |
783,582 | Form 4 |
| 4 | Lopez Fabio EQC Private Markets SAC Fund II Ltd-EQC Biotech Sely S Fund EQC Private Markets SAC Fund Ltd-EQC Biotech Sely I Fund EQC Private Markets SAC Fund Ltd-EQC Biotech Sely II Fund` Equilibria Capital Management Ltd Castilian Ltd. Varibobi Financial Holdings Ltd Tafur Daniel EQC Private Markets II SAC Fund Ltd-EQC Biotech Sely III Fund Former Director, 10% holder Director |
2018-10-09 18:51:04 | 673,671 0 |
673,671 | Form 13D |
| 5 | CICIC DRAGAN SVP, Chief Development Officer |
2025-01-14 17:30:15 | 479,128 0 |
479,128 | Form 4 |
| 6 | Burns John Thomas CFO |
2025-01-14 17:34:56 | 468,562 0 |
468,562 | Form 4 |
| 7 | MAZANET ROSEMARY Chief Medical Officer |
2013-01-31 18:24:03 | 450,000 0 |
450,000 | Form 4 |
| 8 | SCHWARTZ MARK W. President & CEO |
2016-07-06 17:23:17 | 448,481 0 |
448,481 | Form 4 |
| 9 | Woolf Tod President and CEO |
2009-01-20 19:15:27 | 420,100 0 |
420,100 | Form 4 |
| 10 | DiPalma Stephen J. CFO, EVP, Secretary |
2009-01-20 19:12:48 | 369,074 0 |
369,074 | Form 4 |
| 11 | WOOD BARBARA A EVP, Gen. Counsel, Corp. Sec. |
2024-01-25 06:03:53 | 167,225 0 |
167,225 | Form 4 |
| 12 | Pavco Pamela Former VP Pharma Development |
2011-09-27 21:57:05 | 150,000 0 |
150,000 | Form 4 |
| 13 | Dunlap Ryan Former Chief Financial Officer |
2016-06-07 18:36:24 | 144,327 0 |
144,327 | Form 4 |
| 14 | Khvorova Anastasia Former CSO |
2011-09-27 21:01:58 | 137,482 0 |
137,482 | Form 4 |
| 15 | Ahn Mark J President & CEO |
2014-09-19 14:27:25 | 116,225 0 |
116,225 | Form 4/A |
| 16 | KRIEGSMAN STEVEN A Director |
2015-06-23 20:44:33 | 100,000 0 |
100,000 | Form 4 |
| 17 | Beerman Noah D CEO and President |
2011-03-17 20:08:02 | 92,994 0 |
92,994 | Form 4 |
| 18 | Francomano Robert Chief Commercial Officer |
2024-01-25 06:02:10 | 70,918 0 |
70,918 | Form 4 |
| 19 | Hillsberg Sanford Director |
2017-10-10 17:56:56 | 56,950 0 |
56,950 | Form 4 |
| 20 | Kivinski Margaret VP and General Counsel |
2015-01-20 19:17:44 | 50,000 0 |
50,000 | Form 4 |
| 21 | Sarlis Nicholas J. Chief Medical Officer and SVP |
2019-03-18 19:03:32 | 50,000 0 |
50,000 | Form 4 |
| 22 | Nisi Rudolph Director |
2017-10-10 18:01:29 | 42,918 0 |
42,918 | Form 4 |
| 23 | SCHEINBERG DAVID A Director |
2025-01-14 17:34:08 | 41,582 0 |
41,582 | Form 4 |
| 24 | Wasman Jane Director |
2025-01-14 17:33:29 | 41,400 0 |
41,400 | Form 4 |
| 25 | VAN NOSTRAND ROBERT L Director |
2025-01-14 17:33:03 | 41,400 0 |
41,400 | Form 4 |
| 26 | Varian John Director |
2025-01-14 17:30:56 | 41,400 0 |
41,400 | Form 4 |
| 27 | Varanasi Ramani VP Business Development |
2011-03-17 20:18:41 | 41,083 0 |
41,083 | Form 4 |
| 28 | Mack Gene CFO and Treasurer |
2018-04-24 16:53:27 | 40,000 0 |
40,000 | Form 4 |
| 29 | Kalin Katherine Bach Director |
2025-01-14 17:31:54 | 39,500 0 |
39,500 | Form 4 |
| 30 | GRAY MARY ANN Director |
2017-10-10 17:59:12 | 39,167 0 |
39,167 | Form 4 |
| 31 | Ashton William Director |
2017-10-10 17:48:56 | 38,154 0 |
38,154 | Form 4 |
| 32 | GALLIKER STEPHEN S Director |
2017-10-10 17:54:27 | 36,039 0 |
36,039 | Form 4 |
| 33 | Einhorn Irving M. Director |
2017-10-10 17:51:15 | 34,690 0 |
34,690 | Form 4 |
| 34 | Chin Richard Director |
2017-10-10 17:45:21 | 31,339 0 |
31,339 | Form 4 |
| 35 | Torre Gregory M CRO and SVP |
2018-03-15 19:58:21 | 30,000 0 |
30,000 | Form 4 |
| 36 | Nejadnik Bijan Chief Medical Officer |
2017-01-19 19:44:10 | 30,000 0 |
30,000 | Form 4 |
| 37 | Ghiglieri Stephen F Director |
2019-03-18 19:03:09 | 25,000 0 |
25,000 | Form 4 |
| 38 | Andrikopoulos Konstantinos VP, Legal |
2010-04-16 18:04:36 | 15,000 0 |
15,000 | Form 4 |
| 39 | Tata Amy B Principlw Acctg Officer & Cont |
2011-03-17 20:16:11 | 14,065 0 |
14,065 | Form 4 |
| 40 | Knapp Thomas J General Counsel |
2017-02-07 16:58:46 | 10,000 0 |
10,000 | Form 4 |
| 41 | Lee Kwang Principal Accounting Officer |
2011-12-07 16:39:11 | 5,000 0 |
5,000 | Form 4 |
| 42 | HAMILTON BRIAN L EVP, Chief Medical Officer |
2014-07-02 14:25:53 | 4,922 0 |
4,922 | Form 4 |
| 43 | CYTRX CORP 10% Owner |
2011-02-09 11:53:36 | 0 0 |
0 | Form 13G |
| 44 | Krylov Aleksey N. Interim CFO |
2017-12-29 17:00:57 | 0 0 |
0 | Form 3 |
| 45 | Samarsky Dmitry VP, Technology Development |
2010-04-02 09:59:02 | 0 0 |
0 | Form 4 |